tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Merck cuts FY23 adjusted EPS view to $1.33-$1.38 from $2.95-$3.05

FY23 consensus $2.86. Raises FY23 revenue view to $59.7B-$60.2B from $58.6B-$59.6B, consensus $55.98B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on MRK:

Disclaimer & DisclosureReport an Issue

1